Neomycin Polymyxin B Sulfates and Dexamethasone - Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone
Navigation: NDC > Supplier starting with: P > PHOENIX PHARMACEUTICAL, INC.| Field | Value |
|---|---|
| NDC Code: | 57319-347 |
| Proprietary Name: | Neomycin Polymyxin B Sulfates and Dexamethasone |
| Suffix: | |
| Non-Proprietary Name: | Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone |
| Dosage Form: | SUSPENSION/ DROPS |
| Method: | OPHTHALMIC |
| Original Marketing Date: | 13-09-1995 |
| Category Name: | ANDA |
| Application Number: | ANDA064135 |
| Labeler: | PHOENIX PHARMACEUTICAL, INC. |
| Substance Name: | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Active Numerator Strength: | 1; 3.5; 10000 |
| Active Ingredient Unit: | mg/mL; mg/mL; [USP'U]/mL |
| Pharm Classes: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient],Polymyxin-class Antibacterial [EPC],Polymyxins [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| DEA Schedule: |